CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Medium-Chain Triglyceride (MCT) Oildrug
Likely dose
Medium-Chain Triglyceride (MCT) Oil 0.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03630770
NCT03630770Phase 1Completed
CompareCT.gov

Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida

Joseph Bliss·interventional·Posted Aug 15, 2018·Updated Jun 14, 2022

In Brief

A Phase 1 clinical trial evaluating Medium-Chain Triglyceride (MCT) Oil for Candida Infection and Premature Infant. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This study evaluates whether adding a dietary supplement similar to coconut oil (MCT oil) to feedings in premature infants will reduce the amount of yeast (Candida) detectable in their stool. Infants who have Candida in their stool are eligible to participate. Half of the enrolled infants will have additional MCT oil added to their feedings and half will not.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCandida Infection, Premature Infant
CountriesUnited States
CollaboratorsTufts University

Timeline

Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 15, 2018
Enrollment StartJun 5, 2014
Primary CompletionNov 29, 2017
Study CompletionNov 2, 2021
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.9 years ago

Interventions

Medium-Chain Triglyceride (MCT) Oildrug

Infants receive 0.5 ml/oz of MCT oil to their prescribed feedings for 21 days or until hospital discharge.